Notice Information
Notice Title
Oncology Generics Medicines
Notice Description
This Framework Agreement is for the supply of Oncology Generic medicines to NHS Scotland. The Goods have been separated into thirty-nine (39) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.
Lot Information
Lot 1 Bendamustine Powder For Solution For Infusion
Supply of Bendamustine Powder For Solution For Infusion to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 2 Capecitabine TabletsSupply of Capecitabine Tablets to NHS Scotland The Authority has awarded all presentations within this lot to a single supplier.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 3 Carboplatin InjectionSupply of Carboplatin Injections to NHS Scotland The Authority has awarded all presentations within this lot to a single supplier.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 4 Cisplatin InjectionSupply of Cisplatin Injections to NHS Scotland The Authority has awarded all presentations within this lot to a single supplier.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 5 Cyclophosphamide Injection, Powder For ReconstitutionSupply of Cyclophosphamide Injection, Powder For Reconstitution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 6 Cytarabine InjectionsSupply of Cytarabine Injections to NHS Scotland The Authority has awarded all presentations within this lot to a single supplier.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 7 Dacarbazine InjectionsSupply of Dacarbazine Injections to NHS Scotland The Authority has awarded all presentations within this lot to a single supplier.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 8 Disodium Folinate InjectionSupply of Disodium Folinate Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 9 Docetaxel Concentrate For Solution For InfusionSupply of Docetaxel Concentrate For Solution For Infusion to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 10 Doxorubicin Hydrochloride InjectionsSupply of Doxorubicin Hydrochloride Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 13 Fluorouracil 25MG/ML InjectionSupply of Fluorouracil 25MG/ML Injections to NHS Scotland The Authority has awarded all presentations within this lot to a single supplier.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 14 Fluorouracil 50MG/ML InjectionSupply of Fluorouracil 50MG/ML Injections to NHS Scotland The Authority has awarded all presentations within this lot to a single supplier.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 15 Gemcitabine 38MG/ML Concentrate For Solution For Infusion VialsSupply of Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland The Authority has awarded all presentations within this lot to a single supplier.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 16 Gemcitabine 100MG/ML Concentrate For Solution For Infusion VialsSupply of Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland The Authority has awarded all presentations within this lot to a single supplier.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 17 Gemcitabine Powder For Solution For Infusion VialsSupply of Gemcitabine Powder For Solution For Infusion Vials to NHS Scotland. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 18 Idarubicin Hydrochlioride Injection Powder For ReconstitutionSupply of Idarubicin Hydrochlioride Injection Powder For Reconstitution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 19 Ifosfamide Injection Powder For ReconstitutionSupply of Ifosfamide Injection Powder For Reconstitution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 20 Irinotecan Hydrochloride InjectionSupply of Irinotecan Hydrochloride Injection to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 21 Lanreotide Injection Prefilled SyringesSupply of Lanreotide Injection Prefilled Syringes to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 22 Methotrexate Without Preservatives InjectionSupply of Methotrexate Without Preservatives Injection to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 23 Methotrexate Oral SolutionSupply of Methotrexate Oral Solution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 24 Mitomycin Injection Powder For ReconstitutionSupply of Mitomycin Injection Powder For Reconstitution to NHS Scotland. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 25 Oxaliplatin Vial SolutionSupply of Oxaliplatin Vial Solution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 26 Paclitaxel Concentrate For Intravenous InfusionSupply of Paclitaxel Concentrate For Intravenous Infusion to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 27 Temozolomide CapsulesSupply of Temozolomide Capsules to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 28 Vincristine Without Preservatives InjectionSupply of Vincristine Without Preservatives Injection to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 29 Vinorelbine InjectionSupply of Vinorelbine Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 32 Dasatinib TabletsSupply of dasatinib tablets to NHS Scotland. The Authority intends awarding each product line as a multi-supplier unranked framework agreement and it is envisaged a maximum of 3 Suppliers will be awarded. Full details of Goods and volumes can be found within the ITT documents.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 33 PEGFILGRASTIM 6MG PRE-FILLED SYRINGESupply of pegfilgrastim 6mg pre-filled syringe to NHS Scotland. The Authority has awarded this Lot as an unranked multi-supplier Framework to three (3) Framework Participants.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 34 APREPITANT CAPSULESSupply of aprepitant capsules to NHS Scotland. Each product line within this Lot was grouped together and awarded to a single Framework Participant.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 35 TOPOTECAN CAPSULESSupply of topotecan capsules to NHS Scotland. Each product line within this Lot will be grouped together and awarded to a single Framework Participant. Full details of Goods and volumes can be found within the ITT documents.
Renewal: he Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 36 TOPOTECAN CONCENTRATE FOR SOLUTION FOR INFUSIONSupply of topotecan concentrate for solution for infusion to NHS Scotland. Each product line within this Lot was grouped together and awarded to a single Framework Participant.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 37 OCTREOTIDE INJECTIONSupply of Octreotide Injection The Authority has awarded all presentations within this lot to a single supplier.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 38 Filgrastim Pre-Filled SyringeSupply of Filgrastim Pre-Filled Syringe to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single supplier.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 39 ALL OTHER ONCOLOGY GENERIC PRODUCTS/PRESENTATIONSSupply of all other products/presentations within this tender to NHS Scotland. Each product line was treated as an individual Lot, and has been awarded to a single supplier Participant.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 11 ImatinibThe supply of Imatinib to NHS Scotland. The Authority has awarded each product line as a ranked multi-supplier ranked framework agreement to seven (7) Framework Participants.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 12 Etoposide InjectionSupply of Etoposide Injection to NHS Scotland. The Authority has awarded award this Lot as a ranked multi-supplier framework to three (3) Framework Participants.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 30 Octreotide Vials Long Acting (Excluding Homecare)Supply of octreotide vials long acting(excluding homecare) to NHS Scotland The Authority has awarded each product line as a multi-supplier unranked framework agreement to two (2) Framework participants.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Lot 31 Octreotide Vials Long Acting (Including Homecare)Supply of octreotide vials long acting(including homecare) to NHS Scotland. The Authority has awarded each product line as a multi-supplier unranked framework agreement to two (2) Framework participants.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-r6ebe6-0000626685
- Publication Source
- Public Contracts Scotland
- Latest Notice
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB405960
- Current Stage
- Award
- All Stages
- Tender, Award
Procurement Classification
- Notice Type
- OJEU - F3 - Contract Award Notice
- Procurement Type
- Framework
- Procurement Category
- Goods
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Large
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33600000 - Pharmaceutical products
Notice Value(s)
- Tender Value
- £51,839,881 £10M-£100M
- Lots Value
- £51,839,879 £10M-£100M
- Awards Value
- Not specified
- Contracts Value
- £29,082,301 £10M-£100M
Notice Dates
- Publication Date
- 5 Feb 20215 years ago
- Submission Deadline
- 14 Sep 2020Expired
- Future Notice Date
- Not specified
- Award Date
- 16 Dec 20205 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Active, Complete
- Awards Status
- Not Specified
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
- Contact Name
- Available with D3 Tenders Premium →
- Contact Email
- Available with D3 Tenders Premium →
- Contact Phone
- Available with D3 Tenders Premium →
Buyer Location
- Locality
- EDINBURGH
- Postcode
- EH12 9EB
- Postcode Area
- Edinburgh
- Country
- Scotland
-
- Major Region (ITL 1)
- TLM Scotland
- Basic Region (ITL 2)
- TLM1 East Central Scotland
- Small Region (ITL 3)
- TLM13 City of Edinburgh
- Delivery Location
- TLM Scotland
-
- Local Authority
- City of Edinburgh
- Electoral Ward
- Drum Brae/Gyle
- Westminster Constituency
- Edinburgh South West
Further Information
Notice Documents
-
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG392183
Oncology Generics Medicines - This Framework Agreement is for the supply of Oncology Generic medicines to NHS Scotland. The Goods have been separated into thirty-nine (39) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice. -
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB405960
Oncology Generics Medicines - This Framework Agreement is for the supply of Oncology Generic medicines to NHS Scotland. The Goods have been separated into thirty-nine (39) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.
Notice URLs
Open Contracting Data Standard (OCDS)
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.